{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:14:03Z","timestamp":1790424843848,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.exer.2005.03.020","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:47:16Z","timestamp":1118404036000},"page":"610-615","source":"Crossref","is-referenced-by-count":24,"title":["The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients"],"prefix":"10.1016","volume":"81","author":[{"given":"Ciro","family":"Costagliola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Parmeggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Pio","family":"Antinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Caccavale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cotticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2005.03.020_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-4835(05)80123-X","article-title":"Mechanisms of the biphasic effects of peroxides on the retinal vasculature of newborn and adult pigs","volume":"61","author":"Abran","year":"1995","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2005.03.020_bib2","first-page":"463","article-title":"Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development","volume":"80","author":"Abran","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2005.03.020_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian latanoprost study group","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.03.020_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0420.2000.078001071.x","article-title":"Latanoprost: experience of 2-year treatment in Scandinavia","volume":"78","author":"Alm","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.exer.2005.03.020_bib5","first-page":"162","article-title":"Prostaglandins and other eicosanoids: their ocular transport, pharmacokinetics, and therapeutic effects","volume":"105","author":"Bito","year":"1986","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"10.1016\/j.exer.2005.03.020_bib6","first-page":"1126","article-title":"A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: the Proctor lecture","volume":"42","author":"Bito","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.03.020_bib7","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0161-6420(96)30407-7","article-title":"Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.03.020_bib8","first-page":"87","article-title":"Influence of topical administration of diclofenac on the reduction of intraocular pressure induced by timolol in healthy subjects","volume":"14","author":"Castillo Laguarta","year":"1991","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00417-002-0469-8","article-title":"Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side-effects in a prospective study on 76 patients","volume":"240","author":"Costagliola","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-200363001-00005","article-title":"Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis","volume":"63","author":"Duffy","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2005.03.020_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/jop.1994.10.677","article-title":"Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application","volume":"10","author":"Ellis","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.exer.2005.03.020_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0161-6420(03)00227-6","article-title":"Risk factors for hypotony maculopathy","volume":"110","author":"Fannin","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.03.020_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","article-title":"Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review","volume":"25","author":"Gaynes","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.exer.2005.03.020_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0014-4835(86)90085-0","article-title":"Prostaglandin synthesis and release from cultured human trabecular-meshwork cells and scleral fibroblasts","volume":"43","author":"Gerritsen","year":"1986","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2005.03.020_bib15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0002-9394(14)77962-0","article-title":"Effect of topical indomethacin and timolol maleate on intraocular pressure in normal subjects","volume":"99","author":"Goldberg","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1098-3597(01)90069-9","article-title":"Understanding NSAIDs: from aspirin to COX-2","volume":"3","author":"Green","year":"2001","journal-title":"Clin. Cornerstone"},{"key":"10.1016\/j.exer.2005.03.020_bib17","first-page":"1888","article-title":"Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition","volume":"39","author":"Hardy","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.03.020_bib18","first-page":"1127","article-title":"Alterations in arachidonic acid release and phospholipase C-beta(1) expression in glaucomatous human ciliary muscle cells","volume":"43","author":"Husain","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.03.020_bib19","unstructured":"Isaka, M., Sumida, A., Takahashi, K., Azuma, J., 2000. Bromfenac safety to liver: a case for ophthalmic administration. In: Proceedings of Third International Symposium on Ocular Pharmacology and Pharmaceutics (Lisbon, Portugal), Poster Session (Abstract)."},{"key":"10.1016\/j.exer.2005.03.020_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.87.3.297","article-title":"Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost","volume":"87","author":"Kashiwagi","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib21","first-page":"15","article-title":"Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs","volume":"272","author":"Li","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2005.03.020_bib22","first-page":"370","article-title":"Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels","volume":"278","author":"Li","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2005.03.020_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0002-9394(84)90192-2","article-title":"Effect of indomethacin on the ocular hypotensive action of timolol maleate","volume":"98","author":"Lichter","year":"1984","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/S0161-6420(02)01247-2","article-title":"Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients","volume":"109","author":"Liu","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.03.020_bib25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0039-6257(97)80005-7","article-title":"Cyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammation","volume":"41","author":"Masferrer","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/eye.1999.6","article-title":"The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma","volume":"13","author":"McKibbin","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.exer.2005.03.020_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0006-2952(97)00011-7","article-title":"Detection of EP2, EP4, and FP receptors in human ciliary epithelial and ciliary muscle cells","volume":"53","author":"Mukhopadhyay","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2005.03.020_bib28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1248\/bpb.26.1691","article-title":"New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents","volume":"26","author":"Nakajima","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.exer.2005.03.020_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000048305","article-title":"Typical ultrasound biomicroscopic findings seen in ocular hypotony","volume":"216","author":"Roters","year":"2002","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2005.03.020_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000068563","article-title":"Topical nonsteroidal anti-inflammatory therapy in ophthalmology","volume":"217","author":"Schalnus","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2005.03.020_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/108076803322473006","article-title":"Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation","volume":"19","author":"Sharif","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2005.03.020_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1167\/iovs.02-0323","article-title":"Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues","volume":"44","author":"Sharif","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.03.020_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/108076803322660422","article-title":"Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells","volume":"19","author":"Sharif","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2005.03.020_bib34","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0039-6257(02)00302-8","article-title":"Ocular and systemic pharmacokinetics of latanoprost in humans","volume":"47","author":"Sjoquist","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(00)00401-3","article-title":"Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye","volume":"130","author":"Sponsel","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9394(01)01286-7","article-title":"Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy","volume":"133","author":"Sponsel","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.exer.2003.11.016","article-title":"Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment","volume":"78","author":"Stjernschantz","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2005.03.020_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1350-9462(00)00003-3","article-title":"Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment","volume":"19","author":"Stjernschantz","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2005.03.020_bib39","first-page":"170","article-title":"The effect of diclofenac sodium ophthalmic solution on intraocular pressure following cataract extraction","volume":"23","author":"Strelow","year":"1992","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.exer.2005.03.020_bib40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archopht.1991.01080060071027","article-title":"Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol","volume":"109","author":"Sulewski","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib41","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0161-6420(93)31484-3","article-title":"Effects of PhXa41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes","volume":"100","author":"Toris","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.03.020_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.03.020_bib43","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0039-6257(02)00306-5","article-title":"Effects of prostaglandins on the aqueous humor outflow pathways","volume":"47","author":"Weinreb","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2005.03.020_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/exer.1997.0305","article-title":"Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in cultured human ciliary muscle cells: activation of phospholipase A2","volume":"65","author":"Yousufzai","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2005.03.020_bib45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/exer.1996.0119","article-title":"Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species","volume":"63","author":"Yousufzai","year":"1996","journal-title":"Exp. Eye Res."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483505001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483505001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T21:00:22Z","timestamp":1548450022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483505001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0014483505001120"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2005.03.020","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}